National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?-Reference-Cited by-同舟云学术

National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?

Published:2021-01-15 Issue:2 Volume:203 Page:164-167
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Krishnan Jerry A.¹^ORCID,Cloutier Michelle M.²^ORCID,Schatz Michael³^ORCID

Affiliation:

1. University of Illinois at ChicagoChicago, Illinois

2. UCONN HealthFarmington, Connecticutand

3. Kaiser PermanenteSan Diego, California

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference11 articles.

1. National Heart, Lung and Blood Institute. National asthma education and prevention program expert panel report-3: guidelines for the diagnosis and management of asthma. Full Report. Washington, DC; 2007 [accessed 2020 Dec 9]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK7232/.

2. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

3. Generating evidence to inform an update of asthma clinical practice guidelines: Perspectives from the National Heart, Lung, and Blood Institute

4. Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into the anti-asthmatic effect of Raphanus sativus L. (Raphani Semen): Targeting immune cells, inflammatory pathways and oxidative stress markers;Journal of Ethnopharmacology;2024-05

2. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

3. The pharmacological management of asthma in adults: 2023 update;Expert Opinion on Pharmacotherapy;2024-03-03

4. Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States;The Journal of Allergy and Clinical Immunology: In Practice;2023-09

5. Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?;European Respiratory Journal;2023-07-20